Skip to search.
 TSX Up 0.62% TSX Ventures Up 0.23%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
47.75 Up 0.41(0.87%) 11:29AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:47.34
Open:47.08
Bid:47.77 x 300
Ask:47.79 x 100
1y Target Est:46.67
Beta:2.27
Earnings Date:Oct 28 - Nov 2 (Est.)
Day's Range:46.88 - 47.99
52wk Range:30.05 - 52.33
Volume:314,002
Avg Vol (3m):1,012,600
Market Cap:5.96B
P/E (ttm):N/A
EPS (ttm):-0.66
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SGENUp 0.87%5.96B
IMGNUp 1.23%1.56B
PFEUp 1.65%223.65B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.85
Quarterly EPS Est (Sep-15) :-0.21
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-3.20

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback